Archives

Turn Therapeutics: $25 Million Financing Secured By Dermatology Biotechnology Company

By Amit Chowdhry ● Mar 31, 2026

Turn Therapeutics, a clinical-stage dermatology biotechnology company, announced it has secured up to $25 million in financing through a growth capital loan facility with Avenue Capital Group. The agreement includes an initial $7 million tranche funded at closing, with an additional $18 million available upon the achievement of clinical and corporate milestones.

Nuvilab: AI Nutrition Analytics Startup Raises Series A Bridge Funding To Expand In North America

By Amit Chowdhry ● Mar 31, 2026

NAVER’s venture arm NAVER D2SF has made a follow-on investment in Nuvilab, participating in the company’s Series A bridge round as it accelerates expansion into the North American healthcare market.

Niyam Group: J.C. Flowers Invests To Launch Indian Reinsurance Platform And Lloyd’s Syndicate

By Amit Chowdhry ● Mar 31, 2026

J.C. Flowers & Co. has announced an agreement to acquire a controlling stake in Niyam Group while also serving as lead investor in Niyam Syndicate 2047, a newly established syndicate at Lloyd’s. The move marks the creation of a new reinsurance platform designed to connect global capital with opportunities in India and other high-growth markets.

BGO And Bell Partners: $100 Billion Real Estate Investment Management Platform Formed Through Combination

By Amit Chowdhry ● Mar 31, 2026

BGO and Bell Partners announced an agreement to combine their businesses, creating a major U.S. investment management platform with deep expertise in multifamily real estate. The move follows the acquisition of Bell Partners by Sun Life Financial Inc., the parent company of BGO.

Boston Green Company: Fort Point Capital Investment To Expand Environmental Services Platform

By Amit Chowdhry ● Mar 31, 2026

Boston Green Company, an environmental services provider based in Freetown, Massachusetts, has received an investment from Fort Point Capital, marking a recapitalization aimed at accelerating the company’s growth and expansion.

Congruence Therapeutics: $39.5 Million Secured To Advance Small Molecule Correctors Into Clinical Development

By Amit Chowdhry ● Mar 31, 2026

Congruence Therapeutics has announced the closing of a $39.5 million financing to support the advancement of its pipeline of small molecule correctors targeting diseases caused by protein misfolding. The financing round was co-led by Dimension and OrbiMed, with participation from Amplitude Ventures, FSTQ, Lumira Ventures, Investissement Québec, BDC Capital, Driehaus Capital Management, and Silver Arc.

Laigo Bio: €17 Million Raised For Biotech Developing SureTACs Precision Protein Degradation Platform

By Amit Chowdhry ● Mar 31, 2026

Laigo Bio, a Netherlands-based biotech company developing targeted protein degradation therapies, has completed the final close of its oversubscribed seed financing round, bringing the total raised to €17 million.

Posh: $37 Million Raised For Digital Ticketing And Event Management Platform Expansion

By Amit Chowdhry ● Mar 31, 2026

Posh, a NYC-based digital ticketing and event management platform, has raised $37 million in a Series B funding round led by FirstMark, with participation from Causeway Ventures, Goodwater Capital, Companyon Ventures, and Epic Ventures.

Cleavr: $1 Million Raised For AI Accounts Receivable Automation Platform

By Amit Chowdhry ● Mar 31, 2026

Cleavr, a Paris-based developer of an AI-powered accounts receivable automation platform, has raised $1 million in pre-seed funding to accelerate product development and expand across France and broader European markets.